The esophacoil stent for malignant esophageal obstruction.
Esophageal cancer is the seventh most common cause of cancer-related deaths in men in the United States. For a disease in which 60% of patients are incurable at presentation, palliative therapy is the main treatment option. Palliative measures include surgery, radiation therapy, chemotherapy, photodynamic therapy, endoscopic dilation, endoscopic ablation, and the use of endoscopic prostheses. This article reviews the characteristics, technique, efficacy, and complications of the Esophacoil stent for malignant esophageal strictures.
Mayoral
W
W
Department of Medicine, Division of Gastroenterology, Georgetown University Medical Center, Washington, District of Columbia, USA.
Fleischer
D E
DE
D001672:Biocompatible Materials; D004938:Esophageal Neoplasms / Q000150:complications / Q000601:surgery*; D004940:Esophageal Stenosis / Q000209:etiology / Q000601:surgery*; D004945:Esophagoscopy; D006801:Humans; D008670:Metals; D010166:Palliative Care; D011183:Postoperative Complications; D011474:Prosthesis Design; D019919:Prosthesis Implantation / Q000295:instrumentation*; D015607:Stents; D016896:Treatment Outcome
D001672:Biocompatible Materials; D008670:Metals